Multiple Cardiovascular Diseases or Risk Factors Increase the Severity of Coronavirus Disease 2019.
Tomoyuki Yamada,Taku Ogawa,Kenta Minami,Yusuke Kusaka,Masaaki Hoshiga,Akira Ukimura,Takahide Sano,Takeshi Kitai,Taishi Yonetsu,Sho Torii,Shun Kohsaka,Shunsuke Kuroda,Koichi Node,Yuya Matsue,Shingo Matsumoto +14 more
Reads0
Chats0
TLDR
In this paper, a study aimed to determine whether disease severity varied according to whether coronavirus disease 2019 (COVID-19) patients had multiple or single cardiovascular diseases and risk factors (CVDRFs).Abstract:
BACKGROUND: This study aimed to determine whether disease severity varied according to whether coronavirus disease 2019 (COVID-19) patients had multiple or single cardiovascular diseases and risk factors (CVDRFs).MethodsâandâResults:COVID-19 patients with single (n=281) or multiple (n=412) CVDRFs were included retrospectively. Multivariable logistic regression showed no significant difference in the risk of in-hospital death between groups, but patients with multiple CVDRFs had a significantly higher risk of acute respiratory distress syndrome (odds ratio: 1.75, 95% confidence interval: 1.09-2.81). CONCLUSIONS: COVID-19 patients with multiple CVDRFs have a higher risk of complications than those with a single CDVRF.read more
Citations
More filters
Journal ArticleDOI
Cardiovascular considerations during the COVID-19 pandemic: A focused review for practice in Japan.
Daiki Tomidokoro,Yukio Hiroi +1 more
TL;DR: It is demonstrated that in Japanese patients and clinical settings too, there is a close relationship between COVID-19 and the cardiovascular system including cardiovascular complications, and secondary effects on cardiovascular practice including service disruptions, telemedicine, and epidemiological changes in Japan have been relatively small.
References
More filters
Journal ArticleDOI
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang,Yeming Wang,Xingwang Li,Lili Ren,Jianping Zhao,Yi Hu,Li Zhang,Guohui Fan,Jiuyang Xu,Xiaoying Gu,Zhenshun Cheng,Ting Yu,Jia'an Xia,Yuan Wei,Wenjuan Wu,Xuelei Xie,Wen Yin,Li Hui,Min Liu,Yan Xiao,Hong Gao,Li Guo,Jungang Xie,Guang-Fa Wang,Rongmeng Jiang,Zhancheng Gao,Qi Jin,Jianwei Wang,Bin Cao +28 more
TL;DR: The epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of patients with laboratory-confirmed 2019-nCoV infection in Wuhan, China, were reported.
Journal ArticleDOI
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.
Wenhua Liang,Wei-jie Guan,Ruchong Chen,Wei Wang,Jianfu Li,Ke Xu,Caichen Li,Qing Ai,Weixiang Lu,Hengrui Liang,Shiyue Li,Jianxing He +11 more
Journal ArticleDOI
Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis.
Jing Yang,Ya Zheng,Xi Gou,Ke Pu,Zhaofeng Chen,Qinghong Guo,Rui Ji,Haojia Wang,Yuping Wang,Yongning Zhou +9 more
TL;DR: The prevalence of comorbidities in infected patients and risk factors for severe compared with non-severe patients are assessed to help the health sector guide vulnerable populations and assess the risk of deterioration.
Journal ArticleDOI
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.
Zhaohai Zheng,Fang Peng,Buyun Xu,Jingjing Zhao,Huahua Liu,Jiahao Peng,Qingsong Li,Chongfu Jiang,Yan Zhou,Shuqing Liu,Chunji Ye,Peng Zhang,Yangbo Xing,Hangyuan Guo,Weiliang Tang +14 more
TL;DR: Clinical manifestations such as fever, shortness of breath or dyspnea were associated with the progression of disease, and laboratory examination such as aspartate amino transferase(AST) > 40U/L, creatinine(Cr) ≥ 133mol/l, hypersensitive cardiac troponin I(hs-cTnI) > 28pg/mL, procalcitonin(PCT) > 0.5mg/L predicted the deterioration of disease.
Journal ArticleDOI
Potential Effects of Coronaviruses on the Cardiovascular System: A Review.
TL;DR: Coronavirus disease 2019 is associated with a high inflammatory burden that can induce vascular inflammation, myocarditis, and cardiac arrhythmias and should be judiciously controlled per evidence-based guidelines.